Discover Thomson Reuters
The purchase fits Merck's plans to partly focus on acute care in hospitals. Cubist's lead drugs treats infections caused by drug-resistant bacteria. Fred Katayama reports.
01:20
02:10
01:45
07:21
01:58
01:29
02:07
01:53
02:09
01:49
01:05
01:14
00:37
01:10
01:46
01:13
01:37
01:36
01:42